Artivion (US.AORT)
Capital Allocation Audit · Period: 2010 – 2026
Key Metrics
US.AORT · YoY: 2026 Q1 vs 2025 Q1
| Metric | Value | YoY |
|---|---|---|
| FCF Conversion | -593.5% | ↓ |
| ROE | 0.3% | ↑ |
| Cash Conversion | 81.5% | → |
| D/E Ratio | 0.57 | ↑ |
| Gross Margin | 64.9% | → |
US.AORT (Artivion) | YoY: 2026 Q1 vs 2025 Q1 Metric Value YoY ----------------------------- FCF Conversion -593.5% ↓ ROE 0.3% ↑ Cash Conversion 81.5% → D/E Ratio 0.57 ↑ Gross Margin 64.9% →
Key Metrics
US.AORT (Artivion) | YoY: 2026 Q1 vs 2025 Q1
Metric Value YoY-----------------------------FCF Conversion -593.5% ↓ROE 0.3% ↑Cash Conversion 81.5% →D/E Ratio 0.57 ↑Gross Margin 64.9% →Audit Dimensions
Unlimited Companies
AppleMicrosoftAlphabet-AAmazonNVIDIAMeta PlatformsTeslaBerkshire Hathaway-BJPMorganVisaJohnson & JohnsonWalmartProcter & GambleExxon MobilUnitedHealthHome DepotMasterCardPfizerAbbVieCoca-ColaPepsiCoCostcoNetflixAdvanced Micro DevicesSalesforceDisneyNikeBoeingCaterpillarGoldman SachsAlibabaPDD HoldingsJD.comNIO IncLi AutoBaiduTaiwan SemiconductorASML HoldingEli Lilly and CoBroadcomCiscoOracleIntelAT&TVerizonMerck & CoTexas InstrumentsUnited Parcel ServiceRTX CorpLowe's Companies